| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.585 | 0.005 | 0.585 | Diuretic | 0.136 0.089 DBMET00297 0.522 0.007 DBMET02231 0.402 0.013 DBMET02232 0.564 0.005 DBMET02233 0.299 0.022 DBMET02230 | ||
| 0.404 | 0.028 | 0.404 | Cardiotonic | 0.266 0.072 DBMET00297 0.339 0.042 DBMET02231 0.382 0.032 DBMET02232 0.371 0.034 DBMET02233 0.278 0.066 DBMET02230 | ||
| 0.35 | 0 | 0.35 | Bombesin 3 receptor antagonist | 0.261 0.001 DBMET00297 0.294 0.001 DBMET02231 0.308 0.001 DBMET02232 0.307 0.001 DBMET02233 0.263 0.001 DBMET02230 | ||
| 0.341 | 0.027 | 0.403 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.257 0.057 DBMET02231 0.403 0.014 DBMET02232 0.272 0.05 DBMET02233 | DBMET02232 | |
| 0.284 | 0.021 | 0.293 | Focal adhesion kinase 2 inhibitor | 0.216 0.058 DBMET02231 0.293 0.018 DBMET02232 0.206 0.065 DBMET02233 0.146 0.137 DBMET02230 | DBMET02232 | |
| 0.28 | 0.06 | 0.356 | Hypoglycemic | 0.293 0.055 DBMET00297 0.356 0.036 DBMET02231 0.319 0.047 DBMET02233 0.284 0.058 DBMET02230 | DBMET02231 | |
| 0.221 | 0.003 | 0.221 | Bombesin antagonist | 0.106 0.005 DBMET00297 0.169 0.004 DBMET02231 0.156 0.004 DBMET02232 0.179 0.004 DBMET02233 0.106 0.005 DBMET02230 | ||
| 0.253 | 0.036 | 0.27 | LIM domain kinase 1 inhibitor | 0.179 0.074 DBMET02231 0.27 0.029 DBMET02232 0.175 0.077 DBMET02233 | DBMET02232 | |
| 0.214 | 0.004 | 0.239 | Potassium channel (ATP-sensitive) blocker | 0.075 0.033 DBMET00297 0.147 0.005 DBMET02231 0.239 0.003 DBMET02232 0.172 0.004 DBMET02233 | DBMET02232 | |
| 0.221 | 0.035 | 0.253 | Polo-like kinase-3 inhibitor | 0.191 0.05 DBMET02231 0.253 0.023 DBMET02232 0.177 0.06 DBMET02233 | DBMET02232 | |
| 0.188 | 0.002 | 0.188 | Potassium channel Kv1.1 blocker | 0.116 0.004 DBMET02231 0.126 0.004 DBMET02232 0.1 0.004 DBMET02233 | ||
| 0.189 | 0.013 | 0.205 | ALK inhibitor | 0.127 0.026 DBMET02231 0.205 0.011 DBMET02232 0.152 0.019 DBMET02233 | DBMET02232 | |
| 0.23 | 0.056 | 0.27 | MAP kinase kinase 3 inhibitor | 0.203 0.114 DBMET00297 0.207 0.103 DBMET02231 0.27 0.017 DBMET02232 0.204 0.111 DBMET02233 0.203 0.114 DBMET02230 | DBMET02232 | |
| 0.176 | 0.002 | 0.176 | Carbonic anhydrase I stimulant | 0.156 0.003 DBMET00297 0.153 0.003 DBMET02231 0.098 0.005 DBMET02232 0.155 0.003 DBMET02233 0.159 0.003 DBMET02230 | ||
| 0.17 | 0.002 | 0.17 | Bombesin agonist | 0.138 0.003 DBMET00297 0.153 0.002 DBMET02231 0.154 0.002 DBMET02232 0.154 0.002 DBMET02233 0.145 0.002 DBMET02230 | ||
| 0.16 | 0.003 | 0.16 | Carbonic anhydrase II stimulant | 0.143 0.003 DBMET00297 0.139 0.003 DBMET02231 0.09 0.007 DBMET02232 0.142 0.003 DBMET02233 0.145 0.003 DBMET02230 | ||
| 0.147 | 0.002 | 0.147 | Bombesin 3 receptor agonist | 0.116 0.003 DBMET00297 0.13 0.002 DBMET02231 0.131 0.002 DBMET02232 0.132 0.002 DBMET02233 0.123 0.002 DBMET02230 | ||
| 0.142 | 0.005 | 0.169 | ZAP-70 protein tyrosine kinase inhibitor | 0.124 0.007 DBMET02231 0.169 0.005 DBMET02232 0.125 0.007 DBMET02233 | DBMET02232 | |
| 0.14 | 0.005 | 0.14 | Thromboxane antagonist | 0.073 0.024 DBMET00297 0.113 0.008 DBMET02231 0.081 0.019 DBMET02232 0.13 0.006 DBMET02233 0.097 0.012 DBMET02230 | ||
| 0.321 | 0.186 | 0.395 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.395 0.105 DBMET02232 | DBMET02232 | |
| 0.144 | 0.013 | 0.145 | Carbonic anhydrase XII inhibitor | 0.069 0.029 DBMET00297 0.086 0.023 DBMET02231 0.145 0.013 DBMET02232 0.138 0.014 DBMET02233 0.098 0.02 DBMET02230 | DBMET02232 | |
| 0.186 | 0.056 | 0.269 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.147 0.079 DBMET02231 0.269 0.033 DBMET02232 0.161 0.07 DBMET02233 | DBMET02232 | |
| 0.217 | 0.09 | 0.257 | Platelet antagonist | 0.257 0.07 DBMET02231 0.153 0.142 DBMET02232 0.208 0.096 DBMET02233 0.156 0.138 DBMET02230 | DBMET02231 | |
| 0.148 | 0.024 | 0.154 | CC chemokine 6 receptor antagonist | 0.141 0.037 DBMET02231 0.154 0.018 DBMET02232 0.151 0.021 DBMET02233 0.129 0.075 DBMET02230 | DBMET02232 | |
| 0.122 | 0.005 | 0.122 | Thromboxane A2 antagonist | 0.068 0.023 DBMET00297 0.1 0.007 DBMET02231 0.075 0.018 DBMET02232 0.113 0.005 DBMET02233 0.087 0.011 DBMET02230 | ||
| 0.171 | 0.054 | 0.254 | Protein kinase (CK1) gamma 1 inhibitor | 0.155 0.065 DBMET02231 0.254 0.028 DBMET02232 0.114 0.104 DBMET02233 | DBMET02232 | |
| 0.198 | 0.082 | 0.201 | Platelet aggregation inhibitor | 0.201 0.08 DBMET02231 0.159 0.118 DBMET02232 0.173 0.104 DBMET02233 | DBMET02231 | |
| 0.13 | 0.015 | 0.14 | Carbonic anhydrase IX inhibitor | 0.075 0.029 DBMET00297 0.075 0.029 DBMET02231 0.14 0.013 DBMET02232 0.104 0.019 DBMET02233 0.083 0.025 DBMET02230 | DBMET02232 | |
| 0.128 | 0.015 | 0.133 | Thrombin inhibitor | 0.099 0.026 DBMET00297 0.114 0.02 DBMET02231 0.133 0.014 DBMET02232 0.107 0.022 DBMET02233 0.101 0.025 DBMET02230 | DBMET02232 | |
| 0.222 | 0.112 | 0.222 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.122 | 0.014 | 0.122 | Carbonic anhydrase stimulant | 0.082 0.025 DBMET00297 0.087 0.023 DBMET02231 0.075 0.028 DBMET02232 0.084 0.024 DBMET02233 0.096 0.02 DBMET02230 | ||
| 0.116 | 0.022 | 0.193 | Carbonic anhydrase inhibitor | 0.165 0.014 DBMET00297 0.077 0.036 DBMET02231 0.107 0.025 DBMET02232 0.102 0.026 DBMET02233 0.193 0.01 DBMET02230 | DBMET02230 | |
| 0.186 | 0.098 | 0.25 | EphB2 antagonist | 0.25 0.057 DBMET02232 | DBMET02232 | |
| 0.084 | 0.002 | 0.084 | Carbonic anhydrase IV stimulant | 0.072 0.002 DBMET00297 0.069 0.002 DBMET02231 0.028 0.004 DBMET02232 0.069 0.002 DBMET02233 0.075 0.002 DBMET02230 | ||
| 0.151 | 0.074 | 0.17 | Insulin secretagoues | 0.17 0.056 DBMET02231 0.145 0.079 DBMET02232 0.134 0.092 DBMET02233 0.129 0.099 DBMET02230 | DBMET02231 | |
| 0.128 | 0.052 | 0.135 | Interleukin 8 antagonist | 0.116 0.067 DBMET02231 0.135 0.045 DBMET02232 0.121 0.06 DBMET02233 | DBMET02232 | |
| 0.139 | 0.066 | 0.139 | Aurora-C kinase inhibitor | 0.136 0.072 DBMET02231 0.122 0.101 DBMET02232 0.127 0.091 DBMET02233 | ||
| 0.1 | 0.03 | 0.104 | Focal adhesion kinase 1 inhibitor | 0.073 0.058 DBMET02231 0.104 0.027 DBMET02232 0.079 0.05 DBMET02233 | DBMET02232 | |
| 0.165 | 0.101 | 0.227 | Death-associated protein kinase 3 inhibitor | 0.227 0.061 DBMET02232 0.147 0.128 DBMET02233 | DBMET02232 | |
| 0.096 | 0.037 | 0.119 | Somatostatin 1 agonist | 0.119 0.024 DBMET00297 0.096 0.037 DBMET02233 0.109 0.029 DBMET02230 | DBMET00297 | |
| 0.074 | 0.015 | 0.074 | Potassium channel (Inward rectifier) blocker | 0.055 0.028 DBMET02231 0.068 0.018 DBMET02232 | ||
| 0.132 | 0.079 | 0.206 | Protein kinase (CK1) gamma inhibitor | 0.114 0.096 DBMET02231 0.206 0.042 DBMET02232 | DBMET02232 | |
| 0.061 | 0.015 | 0.061 | Collagenase inhibitor | 0.056 0.022 DBMET00297 0.056 0.021 DBMET02231 0.047 0.039 DBMET02232 0.056 0.021 DBMET02233 0.058 0.018 DBMET02230 | ||
| 0.244 | 0.198 | 0.35 | MAP kinase kinase 6 inhibitor | 0.35 0.093 DBMET02232 | DBMET02232 | |
| 0.214 | 0.169 | 0.299 | Sodium/bile acid cotransporter inhibitor | 0.236 0.144 DBMET00297 0.293 0.086 DBMET02233 0.299 0.08 DBMET02230 | DBMET02230 | |
| 0.143 | 0.098 | 0.185 | Protein kinase (CK1) gamma 3 inhibitor | 0.185 0.056 DBMET02232 | DBMET02232 | |
| 0.061 | 0.017 | 0.081 | Fructose-1,6-bisphosphatase inhibitor | 0.053 0.022 DBMET02231 0.081 0.007 DBMET02232 0.046 0.03 DBMET02233 | DBMET02232 | |
| 0.071 | 0.028 | 0.141 | Carbonic anhydrase I inhibitor | 0.105 0.017 DBMET00297 0.075 0.027 DBMET02232 0.055 0.039 DBMET02233 0.141 0.011 DBMET02230 | DBMET02230 | |
| 0.06 | 0.02 | 0.06 | Potassium channel (Inward rectifier) activator | |||
| 0.075 | 0.037 | 0.077 | Bcl2 antagonist | 0.062 0.053 DBMET00297 0.065 0.049 DBMET02231 0.077 0.034 DBMET02232 0.066 0.047 DBMET02233 0.062 0.052 DBMET02230 | DBMET02232 | |
| 0.145 | 0.108 | 0.149 | Cyclin-dependent kinase 3 inhibitor | 0.144 0.112 DBMET00297 0.143 0.115 DBMET02231 0.141 0.12 DBMET02232 0.149 0.099 DBMET02233 | DBMET02233 | |
| 0.068 | 0.031 | 0.122 | Carbonic anhydrase II inhibitor | 0.099 0.019 DBMET00297 0.071 0.029 DBMET02232 0.056 0.038 DBMET02233 0.122 0.014 DBMET02230 | DBMET02230 | |
| 0.047 | 0.01 | 0.062 | Angiotensin AT2 receptor antagonist | 0.048 0.01 DBMET00297 0.021 0.015 DBMET02231 0.031 0.013 DBMET02233 0.062 0.008 DBMET02230 | DBMET02230 | |
| 0.06 | 0.024 | 0.08 | Beta 2 adrenoreceptor antagonist | 0.048 0.039 DBMET00297 0.062 0.022 DBMET02231 0.08 0.012 DBMET02233 | DBMET02233 | |
| 0.056 | 0.02 | 0.056 | Potassium channel (ATP-sensitive) activator | |||
| 0.056 | 0.023 | 0.056 | Aldosterone antagonist | 0.055 0.024 DBMET02232 | ||
| 0.098 | 0.073 | 0.113 | Factor V inhibitor | 0.1 0.069 DBMET00297 0.113 0.046 DBMET02230 | DBMET02230 | |
| 0.056 | 0.035 | 0.059 | Thromboxane synthase inhibitor | 0.052 0.043 DBMET02231 0.059 0.028 DBMET02232 0.057 0.032 DBMET02230 | DBMET02232 | |
| 0.078 | 0.061 | 0.078 | Neuropeptide Y antagonist | |||
| 0.027 | 0.01 | 0.03 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.024 0.016 DBMET02231 0.03 0.008 DBMET02232 0.023 0.016 DBMET02233 | DBMET02232 | |
| 0.049 | 0.034 | 0.07 | Carbonic anhydrase XIV inhibitor | 0.052 0.031 DBMET02231 0.07 0.02 DBMET02232 0.059 0.026 DBMET02233 | DBMET02232 | |
| 0.02 | 0.005 | 0.02 | CC chemokine 10 receptor antagonist | 0.019 0.005 DBMET00297 0.017 0.007 DBMET02231 0.017 0.007 DBMET02232 0.017 0.007 DBMET02233 0.018 0.005 DBMET02230 | ||
| 0.026 | 0.011 | 0.039 | Beta 1 adrenoreceptor agonist | 0.027 0.01 DBMET00297 0.028 0.009 DBMET02231 0.039 0.005 DBMET02233 0.029 0.009 DBMET02230 | DBMET02233 | |
| 0.024 | 0.011 | 0.026 | Angiotensin AT1A receptor antagonist | 0.023 0.012 DBMET00297 0.022 0.015 DBMET02231 0.022 0.014 DBMET02233 0.026 0.008 DBMET02230 | DBMET02230 | |
| 0.054 | 0.042 | 0.075 | Beta 1 adrenoreceptor antagonist | 0.061 0.034 DBMET00297 0.075 0.022 DBMET02233 | DBMET02233 | |
| 0.141 | 0.129 | 0.216 | MAP kinase kinase 2 inhibitor | 0.216 0.072 DBMET02232 | DBMET02232 | |
| 0.032 | 0.025 | 0.038 | Purinergic P2Y2 antagonist | 0.031 0.028 DBMET02231 0.038 0.018 DBMET02232 | DBMET02232 | |
| 0.079 | 0.073 | 0.094 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.094 0.058 DBMET02232 | DBMET02232 | |
| 0.079 | 0.077 | 0.079 | Potassium channel activator | |||
| 0.046 | 0.046 | 0.049 | Alpha 1b adrenoreceptor agonist | 0.049 0.038 DBMET02232 | DBMET02232 | |
| 0.051 | 0.055 | 0.052 | Acetyl-CoA transferase 2 inhibitor | 0.052 0.051 DBMET02233 | DBMET02233 | |
| 0.16 | 0.164 | 0.176 | Calpain inhibitor | 0.176 0.14 DBMET00297 | DBMET00297 | |
| 0.099 | 0.105 | 0.149 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.149 0.065 DBMET02232 | DBMET02232 | |
| 0.053 | 0.06 | 0.057 | Neutrophil collagenase inhibitor | 0.057 0.055 DBMET02231 | DBMET02231 | |
| 0.056 | 0.062 | 0.058 | Trypsin inhibitor | 0.057 0.055 DBMET02232 0.058 0.054 DBMET02230 | DBMET02230 | |
| 0.021 | 0.029 | 0.03 | CXC chemokine 2 receptor antagonist | 0.03 0.014 DBMET02231 0.026 0.019 DBMET02233 | DBMET02231 | |
| 0.044 | 0.052 | 0.055 | CXC chemokine 1 receptor antagonist | 0.055 0.029 DBMET02232 0.051 0.036 DBMET02233 | DBMET02232 | |
| 0.021 | 0.032 | 0.063 | Prostaglandin EP3 antagonist | 0.063 0.008 DBMET00297 0.059 0.008 DBMET02230 | DBMET00297 | |
| 0.038 | 0.051 | 0.174 | Prostaglandin E2 antagonist | 0.124 0.011 DBMET00297 0.174 0.007 DBMET02230 | DBMET02230 | |
| 0.175 | 0.19 | 0.227 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.227 0.129 DBMET02232 | DBMET02232 | |
| 0.065 | 0.081 | 0.115 | Adrenaline agonist | 0.079 0.059 DBMET00297 0.077 0.061 DBMET02231 0.115 0.028 DBMET02233 | DBMET02233 | |
| 0.006 | 0.022 | 0.01 | Beta 3 adrenoreceptor agonist | 0.01 0.009 DBMET02233 | DBMET02233 | |
| 0.053 | 0.069 | 0.077 | Beta adrenoreceptor antagonist | 0.061 0.054 DBMET02231 0.077 0.03 DBMET02233 | DBMET02233 | |
| 0.127 | 0.145 | 0.174 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.174 0.093 DBMET02232 | DBMET02232 | |
| 0.053 | 0.075 | 0.064 | Raf kinase inhibitor | 0.064 0.061 DBMET02232 | DBMET02232 | |
| 0.076 | 0.108 | 0.141 | Electrolyte absorption antagonist | 0.141 0.023 DBMET02232 0.095 0.065 DBMET02230 | DBMET02232 | |
| 0.093 | 0.125 | 0.14 | Vascular endothelial growth factor 3 antagonist | 0.14 0.075 DBMET02232 | DBMET02232 | |
| 0.087 | 0.119 | 0.108 | MAP kinase 12 inhibitor | 0.108 0.086 DBMET02232 | DBMET02232 | |
| 0.118 | 0.153 | 0.428 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.387 0.012 DBMET00297 0.179 0.093 DBMET02231 0.174 0.098 DBMET02232 0.428 0.009 DBMET02230 | DBMET02230 | |
| 0.038 | 0.073 | 0.048 | Beta adrenoreceptor agonist | 0.048 0.023 DBMET02233 | DBMET02233 | |
| 0.063 | 0.109 | 0.122 | Check point kinase 2 inhibitor | 0.122 0.047 DBMET02232 | DBMET02232 | |
| 0.071 | 0.118 | 0.13 | MAP kinase kinase 1 inhibitor | 0.13 0.027 DBMET02231 | DBMET02231 | |
| 0.077 | 0.124 | 0.111 | Protein kinase (CK1) gamma 2 inhibitor | 0.111 0.072 DBMET02232 | DBMET02232 | |
| 0.079 | 0.126 | 0.154 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.154 0.059 DBMET02232 | DBMET02232 | |
| 0.069 | 0.119 | 0.08 | Transforming growth factor beta 3 antagonist | 0.08 0.065 DBMET02232 | DBMET02232 | |
| 0.078 | 0.129 | 0.178 | MAP kinase kinase inhibitor | 0.178 0.037 DBMET02231 | DBMET02231 | |
| 0.096 | 0.149 | 0.12 | Anticoagulant | 0.12 0.112 DBMET02230 | DBMET02230 | |
| 0.16 | 0.23 | 0.282 | Insulysin inhibitor | 0.282 0.07 DBMET02230 | DBMET02230 | |
| 0.081 | 0.151 | 0.119 | Tyrosine kinase inhibitor | 0.119 0.11 DBMET02232 | DBMET02232 | |
| 0.109 | 0.179 | 0.147 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.147 0.078 DBMET02232 | DBMET02232 | |
| 0.054 | 0.125 | 0.113 | Aminopeptidase B inhibitor | 0.113 0.056 DBMET02230 | DBMET02230 | |
| 0.048 | 0.128 | 0.061 | Beta 2 adrenoreceptor agonist | 0.061 0.047 DBMET02233 | DBMET02233 | |
| 0.114 | 0.195 | 0.171 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.171 0.104 DBMET02232 | DBMET02232 | |
| 0.063 | 0.147 | 0.102 | Protein-tyrosine kinase Lyn inhibitor | 0.102 0.1 DBMET02232 | DBMET02232 | |
| 0.078 | 0.169 | 0.138 | Protein kinase C nu inhibitor | 0.138 0.077 DBMET02232 | DBMET02232 | |
| 0.018 | 0.113 | 0.049 | Angiotensin AT1 receptor antagonist | 0.049 0.019 DBMET02230 | DBMET02230 | |
| 0.086 | 0.191 | 0.126 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.126 0.12 DBMET02232 | DBMET02232 | |
| 0.016 | 0.122 | 0.036 | Angiotensin II receptor antagonist | 0.036 0.02 DBMET02230 | DBMET02230 | |
| 0.09 | 0.199 | 0.193 | Platelet adhesion inhibitor | 0.193 0.075 DBMET02231 | DBMET02231 | |
| 0.04 | 0.155 | 0.074 | I kappa B kinase 1 inhibitor | 0.068 0.05 DBMET00297 0.074 0.043 DBMET02232 | DBMET02232 | |
| 0.069 | 0.186 | 0.125 | CDC-like kinase 2 inhibitor | 0.125 0.114 DBMET02232 | DBMET02232 | |
| 0.082 | 0.208 | 0.15 | Hexokinase inhibitor | 0.15 0.079 DBMET02232 | DBMET02232 | |
| 0.013 | 0.142 | 0.049 | Ribonucleoside-diphosphate reductase inhibitor | 0.049 0.041 DBMET00297 | DBMET00297 | |
| 0.012 | 0.151 | 0.047 | Ribonucleotide reductase inhibitor | 0.047 0.044 DBMET00297 | DBMET00297 | |
| 0.016 | 0.158 | 0.055 | Prostaglandin antagonist | 0.055 0.035 DBMET02230 | DBMET02230 | |
| 0.119 | 0.263 | 0.189 | 12-Lipoxygenase inhibitor | 0.189 0.163 DBMET02233 | DBMET02233 | |
| 0.062 | 0.214 | 0.117 | Activin receptor-like kinase 2 inhibitor | 0.117 0.101 DBMET02232 | DBMET02232 | |
| 0.033 | 0.211 | 0.095 | I kappa B kinase inhibitor | 0.095 0.043 DBMET02232 | DBMET02232 | |
| 0.034 | 0.215 | 0.073 | Glutamate dehydrogenase inhibitor | 0.073 0.053 DBMET02230 | DBMET02230 | |
| 0.025 | 0.222 | 0.06 | I kappa B kinase 2 inhibitor | 0.06 0.047 DBMET02232 | DBMET02232 | |
| 0.153 | 0.354 | 0.316 | Cyclophilin D inhibitor | 0.316 0.149 DBMET02231 0.237 0.228 DBMET02233 | DBMET02231 | |
| 0.017 | 0.284 | 0.047 | Carnitine palmitoyltransferase 1B inhibitor | 0.047 0.034 DBMET02230 | DBMET02230 | |
| 0.042 | 0.316 | 0.167 | Mcl-1 antagonist | 0.167 0.075 DBMET02230 | DBMET02230 | |
| 0.02 | 0.332 | 0.078 | GABA aminotransferase inhibitor | 0.078 0.049 DBMET02230 | DBMET02230 | |
| 0.095 | 0.464 | 0.213 | Peptidyltransferase inhibitor | 0.213 0.084 DBMET02231 | DBMET02231 | |
| 0.029 | 0.622 | 0.091 | 3C-Like protease (SARS coronavirus) inhibitor | 0.08 0.067 DBMET00297 0.091 0.044 DBMET02230 | DBMET02230 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |